Affinity Asset Advisors, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1773195
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,478,000
-$7,312,850 QoQ
Shares Held
40,000
-27.3% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#66
of 411 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Jun 30, 2023CallValue
$12,266,100
CallShares
53,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. MDGL ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in MDGL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,478,000 | 40,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $28,790,850 | 55,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,128,826 | 31,131 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $52,745,900 | 115,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,211,200 | 80,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,498,400 | 80,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,457,025 | 82,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,222,000 | 100,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $30,817,600 | 110,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $30,709,600 | 115,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,138,000 | 100,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,413,400 | 85,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,367,500 | 92,500 | Shares | Sole | 2023-08-21 | |
| 2023-06-30 | $12,266,100 | 53,100 | Call | Sole | 2023-08-21 | |
| 2023-03-31 | $22,530,180 | 93,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,317,500 | 70,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,874,250 | 75,000 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $6,499,000 | 100,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,158,000 | 100,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,359,000 | 75,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,508,100 | 65,000 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $555,850 | 5,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||